Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Choong Ang Vaccine Laboratory

+ Add to Watchlist

072020:KS

14,650 KRW 150 1.03%

As of 01:26:37 ET on 03/05/2015.

Snapshot for Choong Ang Vaccine Laboratory (072020)

Open: 14,450 Day's Range: 14,450 - 14,750 Volume: 66,701
Previous Close: 14,500 52wk Range: 11,200 - 19,750 1-Yr Rtn: +25.63%

Stock Chart for 072020

No chart data available.
  • 072020:KS 14,650
  • 1D
  • 1M
  • 1Y
14,500
Interactive 072020 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 072020

Current P/E Ratio (ttm) 20.6629
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.6771
Earnings Per Share (ttm) 709.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 107,238.00
Shares Outstanding (M) 7.32
30 Day Average Volume 140,653
Price/Book (mrq) 2.0751
Price/Sale (ttm) 3.6172
Dividend Indicated Gross Yield 0.34%
Cash Dividend (KRW) 50.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth 0.00%
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 072020

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 072020

Choong Ang Vaccine Laboratory manufactures veterinary vaccines for dog, bovine, poultry, fowls, and cat. The Company provides its products mainly to domestic market.

Yun In-JungRep Director/CEOPark Seung-GiExecutive Director
Jang Bong-HyukExecutive Director
More Company Profile & Key Executives for 072020

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil